言語を選択
新規登録

HLA-C*07:02:01 & B2M & RYR

お問い合わせ

HLA-C*07:02:01 & B2M & RYRバックグランド

HLA-A, B, and C are transmembrane glycoproteins in the major histocompatibility complex 1 (MHC I) family. The C receptor is a heterodimer consisting of a HLA-C mature gene product (heavy chain) and β2-microglobulin (light chain). The mature C chain is anchored in the membrane. HLA class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. HLA-C are expressed in nearly all cells, and present small peptides to the immune system which surveys for non-self peptides.Biotinylated Human HLA-C*07:02:01&B2M&RYR (RYRPGTVAL) Complex Protein is a complex of HLA-C*07:02:01 of the MHC Class I, B2M and RMFPNAPYL peptide of the RYR.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Recombinant humanized anti-IL-6R antibody (Hisun Pharma)HS-628Phase 3 ClinicalZhejiang Hisun Pharmaceutical Co LtdArthritis, Rheumatoid; Arthritis
詳細
VDJ-001Phase 3 ClinicalBeijing Vdjbio Co LtdArthritis, Rheumatoid; Multicentric Castleman's Disease (MCD)
詳細
Tocilizumab biosimilar (AryoGen Pharmed)Phase 3 ClinicalAryogen BiopharmaArthritis, Rheumatoid
詳細
CMAB806CMAB-806Phase 3 ClinicalTaizhou Maibo Taike Biotechnology Co LtdArthritis, Rheumatoid; Arthritis
詳細
LevilimabBCD-089Phase 3 ClinicalBiocadArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
詳細
OlamkiceptFE-999301; CR-5/18; TJ-301; FE-301Phase 2 ClinicalConaris Research InstituteGastrointestinal Diseases; Colitis, Ulcerative
詳細
Atexakin alfaSON-080; r-IL-6Phase 2 ClinicalWeizmann Institute Of SciencePeripheral Nervous System Diseases; Diabetic Neuropathies
詳細
Tocilizumab Biosimilar (qyuns)QX-003-SPhase 1 ClinicalQyuns Therapeutics Co LtdArthritis, Rheumatoid
詳細
Tocilizumab Biosimilar (Destiny)IA-001; IA001Phase 1 ClinicalShanghai Destiny Biotech Co LtdPolyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
TocilizumabrhPM-1; RO-48775533; RG-1569; MRA; HPM-1; MRA-SC; R-1569ApprovedChugai Pharmaceutical Co LtdActemra, RoActemra, 雅美罗, Actemra/RoActemra, ActermaJapanArthritis, Juvenile; Arthritis, Rheumatoid; Giant Cell Arteritis; Takayasu Arteritis; Cytokine Release Syndrome; Multicentric Castleman's Disease (MCD)null2005-04-11Lymphoma; Graves Ophthalmopathy; Ascites; Takayasu Arteritis; Pancreatitis, Chronic; Coronavirus Infections; Pulmonary Arterial Hypertension; Coronary Disease; Lupus Erythematosus, Systemic; Breast Neoplasms; systemic sclerosis-associated interstitial lung disease; Multicentric Castleman's Disease (MCD); Fever; Uveitis, Posterior; Stroke; Pulmonary Disease, Chronic Obstructive; Osteoarthritis; Uveitis; Rejection in heart transplantation; Inflammation; Pleural Effusion, Malignant; Panuveitis; Diabetes Mellitus; Behcet Syndrome; Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Carcinoma, Hepatocellular; Non-ST Elevated Myocardial Infarction; Myocardial Infarction; Hematologic Neoplasms; Solid tumours; Cytokine Release Syndrome; Motor Neuron Disease; HIV Infections; Diabetes Mellitus, Type 1; Acute Chest Syndrome; Craniopharyngioma; Polymyositis; Giant Cell Arteritis; Schnitzler Syndrome; Depressive Disorder, Major; Polyarticular Juvenile Idiopathic Arthritis; Non-radiographic axial spondyloarthritis; Uveitis
詳細
Tocilizumab biosimilar (Bio-Thera Solutions)BAT-1806; BIIB-800ApprovedBio-Thera Solutions Ltd施瑞立, TOFIDENCEMainland ChinaArthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release SyndromeBio-Thera Solutions Ltd2023-01-16Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Arthritis, Juvenile
詳細
SarilumabSAR-153191; REGN-88ApprovedSanofiKevzaraUnited StatesArthritis, RheumatoidSanofi-Synthelabo2017-05-22Non-radiographic axial spondyloarthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Mastocytosis, Systemic; Arthritis, Juvenile; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Uveitis
詳細
Tocilizumab biosimilar (Livzon Group)LZM-008ApprovedLivzon Pharmaceutical Group Inc安维泰Mainland ChinaArthritis, RheumatoidLivzon Mabpharm Inc2023-01-18Arthritis, Rheumatoid
詳細
Tocilizumab biosimilar (Fresenius kabi)MSB-11456ApprovedMerck SeronoTyenne®EUCytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell Arteritis; Coronavirus Disease 2019 (COVID-19)Fresenius Kabi Deutschland Gmbh2023-09-15Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8